Michel Sadelain, one of the fathers of CAR-T, the promising therapies against cancer: "They are living medications that multiply within the patient's body"
Michel Sadelain, a key figure in CAR-T therapy, discusses the advancements in cancer treatment and the ongoing challenges in targeting solid tumors.
The scientists who have revolutionized treatment for different types of blood cancer win the Fronteras prize
American oncologist Carl June and French geneticist Michel Sadelain have been awarded the BBVA Foundation's Fronteras del Conocimiento Prize for their innovative CAR-T cell therapy for blood cancers.
The parents of CAR T therapies against cancer receive the BBVA Foundation Frontiers of Knowledge Award in Biomedicine
Researchers Carl June and Michel Sadelain have been awarded the BBVA Foundation Frontiers of Knowledge Award in Biomedicine for their pioneering work in CAR-T cell therapies that transform cancer treatment.